Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketanserin after LSD in healthy subjects
NCT04558294Phase 1Completed
- Sponsor
- University Hospital Basel
- Start
- Oct 2020
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ketanserin in hallucinogen intoxication, sponsored by University Hospital Basel. Primary endpoints: Duration of subjective response at 12 months and Extent of subjective response at 12 months. Started Oct 2020; status: completed.
02
Drugs
ketanserin
03
Conditions
hallucinogen intoxication
Beyond the preview
Go deeper on NCT04558294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04558294.